ClinicalTrials.gg
WithdrawnNCT02308436Updated Aug 28, 2015

Prophylactic Effect of a CANDIDA Mouthwash, Containing the Curolox™ Peptide

An interventional study of Candida Mouthwash with Curolox™ Peptide in Erosion of Teeth, Unspecified, sponsored by Mibelle AG. Withdrawn at 1 site in Switzerland. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-08-28.

Sponsored by Mibelle AG · Not applicable, Interventional, and Prevention

Why this study was withdrawn
Study is not realised.
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

In vitro results showed a protective effect against acids for the mouthwash containing Curolox™ peptide. The goal of this in situ study is to detect the Curolox™ peptide under natural oral conditions on the tooth surface and to proof the in vitro results obtained. So far there are no effect and safety data of the Curolox™ mouthwash under natural oral conditions available.

Read the detailed description

The primary objective of the study is the detection of the Curolox™ peptide on the bovine enamel sample (proof-of-concept) under in vivo conditions after rinsing with the peptide-containing mouth wash.

Secondary Objectives

The secondary objectives of the study are:

  1. safety and tolerance of the mouthwash in participants
  2. identification of the duration the Curolox™ peptide is present on the bovine tooth surface under in vivo conditions
  3. identification of the most effective mouthwash rinsing volume (2.5 mL or 5 mL)
  4. prophylactic effect of multiple applications of the mouthwash confirmation of the prophylactic effect of the Curolox™ peptide obtained in in vitro study
02

Conditions studied

  • Erosion of Teeth, Unspecified

Browse trials for

03

In context

Tooth Erosion

47 studies on the registry are indexed under Tooth Erosion; 7 are open to participants now.

Browse Tooth Erosion studies →

Lead sponsor

Mibelle AG is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Willing and able to understand and to follow the study procedures and instructions
  • Willing to wear a dental appliance for 7 days
  • Willing and able to attend the on-study visits
  • Good oral hygiene throughout the study
  • Written before participation in the study

Exclusion criteria

Exclusion Criteria:

  • Volunteer with an active periodontal disease or periodontal surgery \< 1 year prior to study participation
  • Volunteer with hypersensitive teeth or with any other (painful) oral pathology or defect
  • Volunteer with an orthodontic appliance
  • Volunteer undergoing a medical treatment
  • Volunteer who is allergic to dental products
  • Pregnant and lactating woman
  • Concurrent participation in another clinical trial
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Candida Mouthwash with Curolox™ Peptide

    Repeated applications 2.5 ml or 5 ml twice daily

    Device: Candida Mouthwash with Curolox™ Peptide

Interventions

  • DeviceCandida Mouthwash with Curolox™ Peptide

    Prophylaxis - protection and care of teeth against caries \& acidic challenges

    Also known as: Candida Protect

06

What researchers measure

Primary outcomes

  1. Detection of Curolox peptide by mass spectroscopy

    The primary outcome is the detection of the Curolox™ peptide on the bovine enamel sample immediately after rinsing with the peptide-containing mouth wash by mass spectroscopy

    Time frame: Immediately after rinsing with the mouthwash

Secondary outcomes

  1. Detection of Curolox peptide by mass spectroscopy

    The secondary outcome is the detection of the Curolox™ peptide on the bovine enamel sample 12 hours, 24 hours, 48 hours and 96 hours after rinsing with the peptide-containing mouth wash by mass spectroscopy

    Time frame: 12 hours, 24 hours, 48 hours, 96 hours

07

Study locations

1 site
  • Aeskulap Klinik
    Brunnen, Switzerland
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Feb 2015, a primary completion of Mar 2015 and a completion of Mar 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 27, 2014
First posted
Dec 4, 2014
Start
Feb 2015
Primary completionEst.
Mar 2015
CompletionEst.
Mar 2015
Last update
Aug 28, 2015
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 28, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02308436
Lead sponsor
Mibelle AG
Responsible party
Sponsor
First posted
Dec 4, 2014
Start date
Feb 2015
Primary completion
Mar 2015 (estimated)
Completion
Mar 2015 (estimated)
Last update
Aug 28, 2015

Study contacts

Christian Besimo, Dr.med.dent.
principal investigator · Aeskulap Klinik
Ulrich P. Saxer, Dr.med.dent.
study director · Aeskulap Klinik / PZZN

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Aug 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion